Buntanetap tartrate for cognitive dysfunction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Nov 2024: Trial registered, NCT06709014
  2. 4 Feb 2025: Trial started, NCT06709014

The trials

NCT06709014: A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

State
Under way
Phase
Phase 3
People
760 planned
Started
4 Feb 2025
Primary completion
Dec 2027
Arms
buntanetap
Results
None posted
  1. 29 Nov 2024: Trial registered
  2. 4 Feb 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Buntanetap/Posiphen.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.